Introduction & Objectives
Extracorporeal shockwave lithotripsy (ESWL) has been used since the 1980s for the non-invasive treatment of urinary stones, however, there has been little advance in providing the operator feedback on the procedure success.
We have previously presented our initial findings of the 'Smart Stethoscope' -a Passive Acoustic Sensor (PAS) which can be used to monitor the effectiveness of ESWL. Characteristics of passive acoustic emissions generated as a shock strikes a stone indicate whether it is effective (on target and causing cavitation). Using the newest prototype (Lithocheck TM ), we have tested the ability of the system to predict the treatment outcome after a 'test dose' of 500 shocks.
Method
A modified 2.5cm sensor was taped to the flank of consented patients with renal stones.
The number of effective shocks were predicted by PAS at 500 and at end of treatment. This was correlated with clinical outcome on follow up X-ray with over 50% fragmentation deemed as successful.
Results
20 treatments have been monitored with the new prototype in 1 month (August -September 2011). 10 patients to date have had follow-up X-ray within 3 weeks, each had 2545±686 shocks. 5 patients showed a stone fragmented of 50% or more 4 patients showed a stone not changed or fragmented less than 50%. 1 patient was excluded as the stone was only 2mm. Figure 4 shows, the difference between the two groups is statistically different at both 500 shocks (218 ± 48 vs 67 ± 49 effective shocks) and at the end of treatment (680 ± 279 vs 244 ± 75 effective shocks).
Conclusion
The initial phase II study shows that there is a high correlation between the number of effective shocks predicted by PAS and clinical outcome. This could be used clinically in the future for assessing whether a stone is suitable for a course of ESWL or if the patient should be offered surgery, thus avoiding the morbidity and financial costs of ineffective ESWL sessions. LITHOCHECK TM
